NEW DELHI, December 1 : World’s first intra-nasal vaccine for COVID developed by India has got approval from the Central Drugs Standard Control Organisation (CDSCO) for restricted use in emergency situations in the age group of 18 and above. This was informed here today by Union Minister of State (Independent Charge) Science & Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh while chairing the meeting of the […]

Related Keywords

Karnataka , India , Telangana , Andhra Pradesh , New Delhi , Delhi , Pune , Maharashtra , Rajesh Gokhale , Narendra Modi , Atmanirbhar Bharat , Jitendra Singh , Atomic Energy , Bharat Biotech International Limited , Central Drugs Standard Control Organisation , Interactive Research School For Health Affairs , Department Of Biotechnology , Earth Sciences , Biotechnology Research , Suraksha Program , Science Technology , National Education , National Institute Of Immunology , Innovation Council , Biotechnology Industry Research Assistance , Union Minister , Independent Charge , Public Grievances , Autonomous Institutions , Biotechnology Institutes , Prime Minister Narendra Modi , National Institute , Immune Monitoring , T Cell Immunoassay , Research School , Health Affairs , Reduction Neutralization , Bharat Biotech , Apex Autonomous Body , Prime Minister Modi , Greater Integration , National Education Policy ,